Immunohistochemical determination of the appropriate anti-hTERT antibodies for in situ detection of telomerase activity in frozen sections of head and neck squamous cell carcinomas and tumor margin tissues

International Journal of Oncology

Volumn 34, Issue 5, 2009, Pages 1257-1279

  Fabricius, Eva Maria ^a   Kruse Boitschenko, Ute ^a   Khoury, Reem ^a   Wildner, Gustav Paul ^b   Raguse, Jan Dirk ^a   Klein, Martin ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Section of Pathology   (Germany)

Author keywords

Frozen sections; Head and neek squamous cell carcinoma; Human telomerase reverse transcriptase; Immunohistochemistry; Prognosis; Telomerae; Tumor margin

Indexed keywords

ACETONE; ALKALINE PHOSPHATASE; CD45 ANTIGEN; ENZYME ANTIBODY; KI 67 ANTIGEN; METHANOL; MONOCLONAL ANTIBODY KI 67; NUCLEOLIN; TELOMERASE REVERSE TRANSCRIPTASE;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ANTIGEN EXPRESSION; ARTICLE; CANCER TISSUE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FROZEN SECTION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOADSORPTION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR LOCALIZATION; WATER VAPOR;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODY SPECIFICITY; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; FROZEN SECTIONS; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; TELOMERASE;

EID: 67649438655     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000254     Document Type: Article

References (112)

1. Slaughter D, Southwick H and Smejkal W: Field cancerization in oral stratified squamous epithelium. Cancer 6: 963-968, 1953.
2. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR and Brakenhoff RH: A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 63: 1727-1730, 2003.
3. Brennan JA, Mao L, Hruban RH, Boyle JO, Eby YJ, Koch WM, Goodman SN and Sidransky D: Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 332: 429-435, 1995.
4. Bryne M: Is the invasive front of an oral carcinoma the most important area for prognostication? Oral Dis 4: 70-77, 1998.
5. Van Houten VM, Tabor MP, van den Brekel MW, Denkers F, Wishaupt RG, Kummer JA, Snow GB and Brakenhoff RH: Molecular assays for the diagnosis of minimal residual headand-neck cancer: methods, reliability, pitfalls, and solutions. Clin Cancer Res 6: 3803-3816, 2000.
6. Van Houten VM, van den Brekel MW, Denkers F, Colnot DR, Westerga J, van Diest PJ, Snow GB and Brakenhoff RH: Molecular diagnosis of head and neck cancer. Recent Results Cancer Res 157: 90-106, 2000.
7. Tabor M, Brakenhoff R, van Houten VMM, Kummer JA, Snel MH, Snijders PJF, Snow GB, Leemans CR and Braakhuis BJM: Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. Clin Cancer Res 7: 1523-1532, 2001.
8. Goldenberg D, Harden S, Masayesva BG, Ha P, Benoit N, Westra WH, Koch WM, Sidransky D and Califano JA: Intraoperative molecular margin analysis in head and neck cancer. Arch Otolaryngol Head Neck Surg 130: 39-44, 2004.
9. Simon C, Koitschev A and Plinkert PK: Gibt es tumorbiologische Besonderheiten, die ein bevorzugtes Auftreten von Rezidiven bei Kopf-Hals-Tumoren begunstigen: Tumorinvasion 'revisited'. Laryngorhinootologie 86: 172-175, 2007.
10. Mao L, El-Naggar AK, Fan Y-H, Lee JS, Lippman SM, Kayser S, Lotan R and Hong WK: Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues. Cancer Res 56: 5600-5604, 1996.
11. Patel MM, Patel DD, Parekh LJ, Raval GN, Rawal RM, Bhatavdekar JM, Patel BP and Patel PS: Evaluation of telomerase activation in head and neck cancer. Oral Oncol 35: 510-515, 1999.
12. Dhaene K, van Marck E and Parwaresch R: Telomeres, telomerase and cancer: an up-date. Virchows Arch 437: 1-16, 2000.
13. Fabricius E-M, Gurr U and Wildner G-P: Telomerase activity levels in the surgical margin and tumour distant tissue of the squamous cell carcinoma of the head-and-neck. Anal Cell Pathol 24: 25-39, 2002.
14. Gurr U: Der Nachweis der Telomeraseaktivierung in Tumorgeweben und dem Tumor benachbarten Geweben von Plattenepithelkarzinomen im Kopf-Hals-Bereich. Dissertation der medizinischen Fakultät der Humboldt-Universität Berlin, pp1-106, 2003.
15. Fabricius E-M: Molecular mechanisms of basal cell and squamous cell carinomas. In: The Role of Telomerase for Cancerogenesis of Basal Cell and Squamous Cell Carcinomas. Landes Bioscience and Springer Science and Bisness Media Inc., New York, pp115-133, 2006.
16. Kim N, Piatyszek M, Prowse K, Harley C, West M, Ho P, Coviello G, Wright W, Weinrich S and Shay J: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994.
17. Hiyama E, Hiyama K, Yokoyama T and Shay JW: Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues. Neoplasia 3: 17-26, 2001.
18. Poremba C, Hero B, Heine B, Scheel C, Schaefer K-L, Christiansen H, Berthold F, Kneif S, Stein H, Juergens H, Boecker W and Dockhorn-Dworniczak B: Telomerase is a strong indicator for assessing the proneness to progression in neuroblastomas. Med Pediatr Oncol 35: 651-655, 2000.
19. Poremba C, Scheel C, Hero B, Christiansen H, Schaefer KL, Nakayama J, Berthold F, Juergens H, Boecker W and Dockhorn-Dworniczak B: Telomerase activity and telomerase subunits gene expression patterns in neuroblastoma: a molecular and immunohistochemical study establishing prognostic tools for fresh-frozen and paraffin-embedded tissues. J Clin Oncol 18: 2582-2592, 2000.
20. Poremba C, Heine B, Diallo R, Heinecke A, Wai D, Schaefer K-L, Braun Y, Schuck A, Lanvers C, Bànkfalvi A, Kneif S, Torhorst J, Zuber M, Köchli OR, Mross F, Dieterich H, Sauter G, Stein H, Fogt F and Boecker W: Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR. J Pathol 198: 181-189, 2002.
21. Yan P, Benhattar J, Seelentag W, Stehle JC and Bosman FT: Immunohistochemical localization of hTERT protein in human tissues. Histochem Cell Biol 121: 391-397, 2004.
22. Park HR, Min SK, Cho HD, Kim KH, Shin HS and Park YE: Expression profiles of p63, p53, surviving, and hTERT in skin tumors. J Cutan Pathol 31: 544-549, 2004.
23. Wu YL, Dudognon C, Nguyen E, Hillion J, Pendino F, Tarkanyi I, Aradi J, Lanotte M, Tong JH, Chen GQ and Segal-Bendirdjian E: Immunodetection of human telomerase reverse-transcriptase (hTERT) re-appraised: nucleolin and telomerase cross paths. J Cell Sci 119: 2797-2806, 2006.
24. Wittekind Ch, Meyer HJ and Bootz F (eds): TNM Klassifikation maligner Tumoren. UICC International Union Against Cancer. 6. Aufl. Korr. Nachdruck. Kopf- und Halstumoren, pp19-52, 2005.
25. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KAF, Stein H and Mason DY: Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32: 219-229, 1984.
26. Fabricius E-M, Langford A, Bier J, Hell B, Wildner G-P and Blümcke S: Immunohistochemical characterization of E48 and CD44-v6 expression in head and neck carcinomas. Cancer J 10: 325-330, 1997.
27. Fabricius E-M, Guschmann M, Wildner G, Langford A, Hell B and Bier J: Divergent immunohistochemical E48 and CD44-v6 antigen expression patterns between lymph node metastases and primary squamous cell carcinomas in the head and neck region. Cancer J 11: 325-330, 1998.
28. Fabricius E-M, Guschmann M, Langford A, Hell B and Bier J: Immunhistochemical assessment of the tumour-associated epitopes CD44v6 and E48 in tumour-free lymph nodes from patients with squamous cell carcinoma in the head-neck region. Anal Cell Pathol 20: 115-129, 2000.
29. Remmele W, Hildebrand U, Hienz HA, Klein P-J, Vierbuchen M, Behnken LJ, Heicke B and Scheidt E: Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer. Virchows Arch A 409: 127-147, 1986.
30. Remmele W and Stegner HE: Vorschlag zur einheitlichen Definition eines immunreaktiven Score (IRE) für den immunohistochemischen Östrogenrezeptor-Nachweis (ER-ICA) im Mammagewebe. Pathologie 8: 138-140, 1987.
31. Alpha Diagnostics International (USA): Demonstration by antibody specificity of antigen (peptide/protein) blocking: 1, 1996.
32. Abcam (USA): Blocking with immunizing peptide (BL) protocol. 1, 2006.
33. Frost M, Bobak J, Gianani R, Kim N, Weinrich S, Spalding D, Cass L, Thompson L, Enomoto T, Uribe-Lopez D and Shroyer K: Localization of telomerase hTERT protein and hTR in benign mucosa, dysplasia, and squamous cell carcinoma of the cervix. Am J Clin Pathol 114: 726-734, 2000.
34. Sachs L: Angewandte Statistik - Anwendung statistischer Methoden. 11. Auflage Springer Verlag, Berlin, Heidelberg, p889, 2004.
35. Diehl JM and Staufenbiel T: Statistik mit SPSS für Windows Version 15. Verlag Dietmar Klotz, Eschborn, p720, 2007.
36. Kolquist K, Ellisen L, Counter C, Meyerson M, Tan L, Weinberg R, Haber D and Gerald W: Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nat Genet 19: 182-186, 1998.
37. Park T, Riethdorf S, Riethdorf L, Löning T and Jänicke F: Differential telomerase activity, expression of the telomerase catalytic sub-unit and telomerase-RNA in ovarian tumors. Int J Cancer 84: 426-431, 1999.
38. Chou S, Chen C, Harn H, Chen C and Liu Y: In situ detection of hTERT mRNA relates to Ki-67 labeling index in papillary thyroid carcinoma. J Surg Res 99: 75-83, 2001.
39. Kim H-R, Christensen R, Park N-H, Sapp P, Kang M and Park N-H: Elevated expression of hTERT is associated with dysplastic cell transformation during human oral carcinogenesis in situ. Clin Cancer Res 7: 3079-3086, 2001.
40. Dhaene K, Wauters J, Weyn B, Timmermans J and van Marck E: Expression profile of telomerase subunits in human pleural mesothelioma. J Pathol 190: 80-85, 2000.
41. Tahara H, Yasui W, Tahara E, Fujimoto J, Ito K, Tamai K, Nakayama J, Ishikawa F, Tahara E and Ide T: Immunohistochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections. Oncogene 18: 1561-1567, 1999.
42. Kawakami Y, Kitamoto M, Nakanishi T, Yasui W, Tahara E, Nakayama J, Ishikawa F, Tahara H, Ide T and Kajiyama G: Immunohistochemical detection of human telomerase reverse transcriptase in human liver tissues. Oncogene 19: 3888-3893, 2000.
43. Wada H, Enomoto T, Yoshino K, Ozaki K, Kurachi H, Nomura T, Murata Y, Kim N, Weinrich S, Lea-Chou E, Lopez-Uribe D and Shroyer K: Immunohistochemical localization of telomerase hTERT protein and analysis of clonality in multifocal vulvar intraepithelial neoplasia. Am J Clin Pathol 114: 371-379, 2000.
44. Lehner R, Bobak J, Kim N, Shroyer A and Shroyer K: Localization of telomerase hTERT protein and survivin in placenta: relation to placental development and hydatidiform mole. Obstet Gynecol 97: 965-970, 2001.
45. Lehner R, Enomoto T, McGregor J, Shroyer A, Haugan B, Pugazhenthi U and Shroyer K: Quantitative analysis of telomerase hTERT mRNA and telomerase activity in endometrioid adenocarcinoma and in normal endometrium. Gynecol Oncol 84: 120-125, 2002.
46. Yang S, Zhang B, Wang J, Liao S, Han J, Wei J and Hou L: Monoclonal antibodies against human telomerase reverse transcriptase (hTERT): preparation, characterization, and application. Hybridoma 20: 249-255, 2001.
47. Nguyen DC, Parsa B, Close A, Magnusson B, Crowe DL and Sinha UK: Overexpression of cell cycle regulatory proteins correlates with advanced tumor stage in head and neck squamous cell carcinomas. Int J Oncol 22: 1285-1290, 2003.
48. Kumar SK, Zain RB, Ismail SM and Cheong SC: Human telomerase reverse transcriptase expression in oral carcinogenesis - a preliminary report. J Exp Clin Cancer Res 24: 639-646, 2005.
49. Luzar B, Poljak M and Gale N: Telomerase catalytic subunit in laryngeal carcinogenesis - an immunohistochemical study. Mod Pathol 18: 406-411, 2005.
50. Chen HH, Yu CH, Wang JT, Liu BY, Wang YP, Sun A, Tsai TC and Chiang CP: Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan. Oral Oncol 43: 122-129, 2007.
51. Freier K, Pungs S, Flechtenmacher C, Bosch FX, Lichter P, Joos S and Hofele C: Frequent high telomerase reverse transcriptase expression in primary oral squamous cell carcinoma. J Oral Pathol Med 36: 267-272, 2007.
52. Gonzalez-Quevedo R, De Juan C, Massa M, Sanchez-Pernaute A, Torres A, Balibrea J, Benito M and Iniesta P: Detection of telomerase activity in human carcinomas using a trap-ELISA method: correlation with hTR and hTERT expression. Int J Oncol 16: 623-628, 2000.
53. Fujimoto S, Kamata N, Yokoyama K, Ueda N, Satomura K, Hayashi E and Nagayama M: Expression of telomerase components in oral keratinocytes and squamous cell carcinomas. Oral Oncol 37: 132-140, 2001.
54. Hoang-Vu C, Boltze C, Gimm O, Poremba C, Dockhorn-Dworniczak B, Kohrle J, Rath FW and Dralle H: Expression of telomerase genes in thyroid carcinoma. Int J Oncol 21: 265-272, 2002.
55. Malaska J, Kunicka Z, Borsky M, Sklenickova M, Novotna M, Fajkusova L, Zaloudik J and Fajkus J: Telomerase as a diagnostic and predictive marker in colorectal carcinoma. Neoplasma 51: 90-96, 2004.
56. Kyo S, Masutomi K, Maida Y, Kanaya T, Yatabe N, Nakamura M, Tanaka M, Takarada M, Sugawara I, Murakami S, Taira T and Inoue M: Significance of immunological detection of human telomerase reverse transcriptase: re-evaluation of expression and localization of human telomerase reverse transcriptase. Am J Pathol 163: 859-867, 2003.
57. Yan P, Coindre JM, Benhattar J, Bosman FT and Guillou L: Telomerase activity and human telomerase reverse transcriptase mRNA expression in soft tissue tumors: correlation with grade, histology, and proliferative activity. Cancer Res 59: 3166-3170, 1999.
58. Shay J, Zou Y, Hiyama E and Wright W: Telomerase and cancer. Hum Mol Genet 10: 677-685, 2001.
59. Etheridge K, Banik S, Armbruster BZY, Tern R, Terns M and Counter C: The nucleolar localization domain of the catalytic subunit of human telomerase. J Biol Chem 277: 24764-24770, 2002.
60. Wu A, Ichihashi M and Ueda M: Correlation of the expression of human telomerase subunits with telomerase activity in normal skin and skin tumors. Cancer 86: 2038-2044, 1999.
61. Pannone G, De Maria S, Zamparese R, Metafora S, Serpico R, Morelli F, Rubini C, Farina E, Carteni M, Staibano S, De Rosa G, Lo Muzio L and Bufo P: Prognostic value of human telomerase reverse transcriptase gene expression in oral carcinogenesis. Int J Oncol 30: 1349-1357, 2007.
62. Wei R and Younes M: Immunohistochemical detection of telomerase reverse transcriptase in colorectal adenocarcinoma and benign colonic mucosa. Hum Pathol 33: 693-696, 2002.
63. Lam AK, Ong K and Ho YH: hTERT expression in colorectal adenocarcinoma: correlations with p21, p53 expressions and clinicopathological features. Int J Colorectal Dis 23: 587-594, 2008.
64. Lantuejoul S, Soria JC, Moro-Sibilot D, Morat L, Veyrenc S, Lorimier P, Brichon PY, Sabatier L, Brambilla C and Brambilla E: Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours. Br J Cancer 90: 1222-1229, 2004.
65. Toomey D, Smyth G, Condron C, Kay E, Conroy R, Foley D, Hong C, Hogan B, Toner S, McCormick P, Broe P, Kelly C and Bouchier-Haynes D: Immune function, telomerase, and angiogenesis in patients with primary, operable non-small cell lung carcinoma. Tumor size and lymph node status remain the most important prognostic features. Cancer 92: 2648-2657, 2001.
66. Tabori U, Wong V, Ma J, Shago M, Alon N, Rutka J, Bouffet E, Bartels U, Malkin D and Hawkins C: Telomere maintenance and dysfunction predict recurrence in paediatric ependymoma. Br J Cancer 99: 1129-1135, 2008.
67. Elkak AE, Meligonis G, Salhab M, Mitchell B, Blake JR, Newbold RF and Mokbel K: hTERT protein expression is independent of clinicopathological parameters and c-Myc protein expression in human breast cancer. J Carcinog 4: 17-22, 2005.
68. Mavrommatis J, Mylona E, Gakiopoulou H, Stravodimos C, Zervas A, Giannopoulos A and Nakopoulou L: Nuclear hTERT immunohistochemical expression is associated with survival of patients with urothelial bladder cancer. Anticancer Res 25: 3109-3116, 2005.
69. Volpi A, Bravaccini S, Medri L, Cerasoli S, Gaudio M and Amadori D: Usefulness of immunological detection of the human telomerase reverse transcriptase. Cell Oncol 27: 347-353, 2005.
70. Taylor CR, Shi SR, Chen C, Young L, Yang C and Cote RJ: Comparative study of antigen retrieval heating methods: microwave, microwave and pressure cooker, autoclave, and steamer. Biotech Histochem 71: 263-270, 1996.
71. DakoCytomation: Handbuch Immunchemische Färbemethoden. Boenisch T (ed). 3. Aufl. ed, pp1-86, 2003.
72. Kleinschmidt K: Inaugural-Dissertation zur Erlangung des Grades einer Doktorin der Veterinärmedizin (Dr. med. vet.) durch die Tierärztliche Hochschule Hannover: Untersuchung von Endostatin freisetzenden Stammzellimplantaten zur Behandlung des Glioblastoms im Rattenmodell, pp1-207, 2006.
73. Hiyama E and Hiyama K: Telomerase as tumor marker. Cancer Lett 194: 221-233, 2003.
74. Hiyama E and Hiyama K: Telomerase detection in the diagnosis and prognosis of cancer. Cytotechnology 45: 61-74, 2004.
75. Miyazu YM, Miyazawa T, Hiyama K, Kurimoto N, Iwamoto Y, Matsuura H, Kanoh K, Kohno N, Nishiyama M and Hiyama E: Telomerase expression in noncancerous bronchial epithelia is a possible marker of early development of lung cancer. Cancer Res 65: 9623-9627, 2005.
76. Hashimoto Y, Murakami Y, Uemura K, Hayashidani Y, Sudo T, Ohge H, Fukuda E, Sueda T and Hiyama E: Detection of human telomerase reverse transcriptase (hTERT) expression in tissue and pancreatic juice from pancreatic cancer. Surgery 143: 113-125, 2008.
77. Ohkoudo M, Sawa H, Shiina Y, Sato H, Kamata K, Iijima J, Yamamoto H, Fujii M and Saito I: Morphometrical analysis of nucleolin immunohistochemistry in meningiomas. Acta Neuropathol (Berl) 92: 1-7, 1996.
78. Bettendorf O, Heine B, Kneif S, Eltze E, Semjonow A, Herbst H, Stein H, Bocker W and Poremba C: Expression-patterns of the RNA component (hTR) and the catalytic subunit (hTERT) of human telomerase in nonneoplastic prostate tissue, prostatic intraepithelial neoplasia, and prostate cancer. Prostate 55: 99-104, 2003.
79. Seo EJ, Kim HJ, Lee CJ, Kang HT and Hwang ES: The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cell. Gynecol Oncol 94: 40-47, 2004.
80. Boltze C, Mundschenk J, Unger N, Schneider-Stock R, Peters B, Mawrin C, Hoang-Vu C, Roessner A and Lehnert H: Expression profile of the telomeric complex discriminates between benign and malignant pheochromocytoma. J Clin Endocrinol Metab 88: 4280-4286, 2003.
81. Forsyth R, De Boeck G, Bekaert S, De Meyer T, Taminiau A, Uyttendaele D, Roels H, Praet M and Hogendoorn P: Telomere biology in giant cell tumour of bone. J Pathol 214: 555-563, 2008.
82. Masutomi K, Yu E, Khurts S, Ben-Porath I, Currier J, Metz G, Brooks M, Kaneko S, Murakami S, De Caprio J, Weinberg R, Stewart S and Hahn W: Telomerase maintains telomere structure in normal human cells. Cell 114: 241-253, 2003.
83. Lin J, Jin R, Zhang B, Yang PX, Chen H, Bai YX, Xie Y, Huang C and Huang J: Characterization of a novel effect of hPinX1 on hTERT nucleolar localization. Biochem Biophys Res Commun 353: 946-952, 2007.
84. Tomlinson RL, Ziegler TD, Supakorndej T, Terns RM and Terns MP: Cell cycle-regulated trafficking of human telomerase to telomeres. Mol Biol Cell 17: 955-965, 2006.
85. Nakamura K, Kaneko T, Yamashita Y, Hasegawa H, Katoh H, Ichikawa A and Negishi M: Immunocytochemical localization of prostaglandin EP3 receptor in the rat hypothalamus. Neurosci Lett 260: 117-120, 1999.
86. Klinck R, Serup P, Madsen OD and Jorgensen MC: Specificity of four monoclonal anti-NKx6-1 antibodies. J Histochem Cytochem 56: 415-424, 2008.
87. Wong JM, Kusdra L and Collins K: Subnuclear shuttling of human telomerase induced by transformation and DNA damage. Nat Cell Biol 4: 731-736, 2002.
88. Zhu Y, Tomlinson RL, Lukowiak AA, Terns RM and Terns MP: Telomerase RNA accumulated in cajal bodies in human cancer cells. Mol Biol Cell 15: 81-90, 2004.
89. Yang Y, Chen Y, Zhang C, Huang H and Weissman SM: Nucleolar localization of hTERT protein is associated with telomerase function. Exp Cell Res 277: 201-209, 2002.
90. Lin J, Jin R, Zhang B, Chen H, Bai YX, Yang PX, Han SW, Xie YH, Huang PT, Huang C and Huang JJ: Nucleolar localization of TERT is unrelated to telomerase function in human cells. J Cell Sci 121: 2169-2176, 2008.
91. Khurts S, Masutomi K, Delgermaa L, Arai K, Oishi N, Mizuno H, Hayashi N, Hahn WC and Murakami S: Nucleolin interacts with telomerase. J Biol Chem 279: 51508-51515, 2004.
92. Ginisty H, Sicard H, Roger B and Bouvet P: Structure and functions of nucleolin. J Cell Sci 112: 761-772, 1999.
93. Yajima Y, Noma H, Furuya Y, Nomura T, Yamauchi T, Kasahara K, Hatada K and Takano M: Quantification of telomerase activity of regions unstained with iodine solution that surround oral squamous cell carcinoma. Oral Oncol 40: 314-320, 2004.
94. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek M-A, Shay J-W, Ishioka S and Yamakido M: Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 155: 3711-3715, 1995.
95. Yamada O, Motoji T and Mizoguchi H: Up-regulation of telomerase activity in human lymphocytes. Biochim Biophys Acta 1314: 260-266, 1996.
96. Counter C-M, Gupta J, Harley C-B, Leber B and Bacchetti S: Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 85: 2315-2320, 1995.
97. Broccoli D, Young JW and De Lange T: Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 92: 9082-9086, 1995.
98. Bodnar AG, Kim NW, Effros RB and Chiu CP: Mechanism of telomerase induction during T cell activation. Exp Cell Res 228: 58-64, 1996.
99. Shay JW and Wright WE: Telomerase activity in human cancer. Curr Opin Oncol 8: 66-71, 1996.
100. Guo M, Rabin B, Johnson J and Paradis I: Lymphocytic phenotypes at tumor margins in patients with head and neck cancer. Head Neck Surg 9: 265-271, 1987.
101. Kannan S, Tahara H, Yokozaki H, Mathew B, Nalinakumari K, Nair M and Tahara E: Telomerase activity in premalignant and malignant lesions of human oral mucosa. Cancer Epidemiol Biomarkers Prev 6: 413-420, 1997.
102. Takes RP: Staging of the neck in patients with head and neck squamous cell cancer: imaging techniques and biomarkers. Oral Oncol 40: 656-667, 2004.
103. Feinmesser M, Okon E, Schwartz A, Kaganovsky E, Hardy B, Aminov E, Nageris B, Sulkes J and Feinmesser R: Histologic and immunohistochemical characterization of tumor and inflammatory infiltrates in oral squamous cell carcinomas treated with local multikine immunotherapy: the macrophage at the front line. Eur Arch Otorhinolaryngol 261: 359-368, 2004.
104. Hohaus S, Cavallo S, Bellacosa A, Genuardi M, Galli J, Cadoni G, Almadori G, Lauriola L, Litwin S, Maurizi M and Neri G: Telomerase activity in human laryngeal squamous cell carcinomas. Clin Cancer Res 2: 1895-1900, 1996.
105. Eissa S, Kenawy G, Moteleb FA, El-Magkhzangy AN and Nassar M: Real-time PCR hTERT mRNA pattern in tumor core, edge, resection margin, and lymph nodes in laryngeal tumors: relation to proliferative index and impact on prognosis. Clin Biochem 28: 873-878, 2005.
106. Xiao Y, Gao X, Gannot G, Emmert-Buck MR, Srivastava S, Wagner PD, Amos MD and Barker PE: Quantitation of HER2 and telomerase biomarkers in solid tumors with IgY antibodies and nanocrystal detection. Int J Cancer 122: 2178-2186, 2008.
107. Lantuejoul S, Salon C, Soria J-C and Brambilla E: Mini review: telomerase expression in lung preneoplasia and neoplasia. Int J Cancer 120: 1835-1841, 2007.
108. Burnworth B, Arendt S, Muffler S, Steinkraus V, Brocker EB, Birek C, Hartschuh W, Jauch A and Boukamp P: The multistep process of human skin carcinogenesis: a role for p53, cyclin D1, hTERT, p16, and TSP-1. Eur J Cell Biol 86: 763-780, 2007.
109. Cassaro M, Rugge M, Tieppo C, Giacomelli L, Velo D, Nitti D and Farinati F: Indefinite for non-invasive neoplasia lesions in gastric intestinal metaplasia: the immunophenotype. J Clin Pathol 60: 615-621, 2007.
110. Olsen SH, Su LD, Thomas D and Fullen DR: Telomerase expression in sebaceous lesions of the skin. J Cutan Pathol 34: 386-391, 2007.
111. Zendehrokh N, Rehnberg J and Dejmek A: Comparison of NCLhTERT antibody reactivity and telomere repeat amplification protocol in situ in effusions. Acta Cytol 51: 886-892, 2007.
112. Yang CH, Hung WC, Wang SL, Kang WY, Chen WT, Huang YC, Su YC and Chai CY: Immunoexpression and prognostic role of hTERT and cyclin D1 in urothelial carcinoma. APMIS 116: 309-316, 2008.